<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127719">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01861275</url>
  </required_header>
  <id_info>
    <org_study_id>36/2013</org_study_id>
    <secondary_id>36/2013</secondary_id>
    <secondary_id>36/2013 UO</secondary_id>
    <nct_id>NCT01861275</nct_id>
  </id_info>
  <brief_title>Cerebral Palsy and Sleep Apnea in North Part of Finland</brief_title>
  <official_title>Obstructive Sleep Apnea as a Risk Factor for Cerebral Palsy, a Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep apnoea is a risk factor for cerebral palsy. study hypothesis: In
      prospective study the investigators want to know how many cerebral palsy patients have sleep
      apnoea and does thrombolysis play a role in severity of osa in six months follow up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In prospective study the investigators include all over 18 years old patients who came to
      emergency room for cerebral palsy.Exclusion criteria is not able to co-operate or need for
      intensive care unit.The investigators shall take 100 control patients who have cerebral
      palsy and no thrombolysis and 100 study patients who will have thrombolysis. The
      investigators do sleep registration during hospital staying within 2 days after patients
      have felt ill.Follow-up registration will be done after 6 months at home.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>cerebral palsy events and severity of osa</measure>
    <time_frame>from six months to twenty four months</time_frame>
    <safety_issue>No</safety_issue>
    <description>in prospective study outcome measure is severity of osa in 6months follow-up</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Sleep Apnoea</condition>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>cpap</arm_group_label>
    <description>Nasal-cpap treatment and compliance in sleep apnea patients with cerebral palsy.
No Nasal-cpap treatment in sleep apnea patients with cerebral palsy. Severity of sleep apnea in thrombolysis patients and in control patients. Thrombolysis reduces severity of sleep apnea.Sleep apnea is common among cerebral palsy patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no cpap</arm_group_label>
    <description>No nasal-cpap in sleep apnea patients with cerebral palsy</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        residents of Oulu university hospital area. consecutive patient sampling
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 18 years old patients that have cerebral palsy and are able to participate to
             the study.

        Exclusion Criteria:

          -  no co-operation and need for intensive care unit
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tarja Saaresranta, Md PhD</last_name>
    <role>Study Director</role>
    <affiliation>University hospital of Turku</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaana Huhtakangas, MD</last_name>
    <phone>+35883154038</phone>
    <email>jaana.huhtakangas@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juha Huhtakangas, MD, PhD</last_name>
    <phone>+35883154032</phone>
    <email>juha.huhtakangas@ppshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oulu university hospital,department of neurology</name>
      <address>
        <city>Oulu</city>
        <state>northern Finland</state>
        <zip>90029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juha Huhtakangas, Md PhD</last_name>
      <phone>+35883154032</phone>
      <email>juha.huhtakangas@ppshp.fi</email>
    </contact>
    <contact_backup>
      <last_name>Jaana huhtakangas, Md</last_name>
      <phone>+358083154038</phone>
      <email>jaana.huhtakangas@ppshp.fi</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 22, 2013</lastchanged_date>
  <firstreceived_date>May 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osa</keyword>
  <keyword>cerebral palsy</keyword>
  <keyword>thrombolysis in cerebral palsy</keyword>
  <keyword>sleep registration</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Paralysis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
